Letters to the Editor

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival

Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
Otto von Guericke University Hospital Magdeburg, Magdeburg, Germany
Haukeland University Hospital, Bergen, Norway
Dutch-Belgian Hemato-Oncology Cooperative Group Data Center–Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius, Lithuania
Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
Skanes University Hospital, Lund, Sweden
University Hospital Gasthuisberg, Leuven, Belgium
University Hospital, Zurich, Switzerland; Swiss Group for Clinical Cancer Research(SAKK), Bern, Switzerland
Swiss Group for Clinical Cancer Research(SAKK), Bern, Switzerland; Department of Medical Oncology, Inselspital; University Hospital, Bern, Switzerland
Swiss Group for Clinical Cancer Research(SAKK), Bern, Switzerland; University Hospital, Basel, Switzerland
Helsinki University Hospital Cancer Center, Helsinki, Finland
Erasmus University Medical Center (MC) and Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Erasmus University Medical Center (MC) and Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
Vol. 108 No. 10 (2023): October, 2023 https://doi.org/10.3324/haematol.2022.282639